Form 8-K - Current report:
SEC Accession No. 0001585364-25-000054
Filing Date
2025-05-07
Accepted
2025-05-07 06:41:21
Documents
16
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prgo-20250507.htm   iXBRL 8-K 43932
2 EX-99.1 cy25q1ex991pressrelease.htm EX-99.1 746264
7 perrigoimagenew.jpg GRAPHIC 18151
  Complete submission text file 0001585364-25-000054.txt   1063903

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20250507.xsd EX-101.SCH 3971
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20250507_def.xml EX-101.DEF 17935
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20250507_lab.xml EX-101.LAB 33694
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20250507_pre.xml EX-101.PRE 18907
19 EXTRACTED XBRL INSTANCE DOCUMENT prgo-20250507_htm.xml XML 7042
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 25919172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)